http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Altria Group (MO) Reaffirms 2020 Full-Year Earnings Guidance
-
Altria Participates in the Barclays Global Consumer Staples Conference; Reaffirms 2020 Full-Year Earnings Guidance
-
Appaloosa's 13F Shows New Stakes in Altria (MO), AT&T Inc (T), Disney (DIS), PayPal (PYPL) (More...)
-
Altria Reports 2020 Second Quarter and First-Half Results; Reestablishes 2020 Full-Year Earnings Guidance; Announces IQOS Expansion Plans; Board Declares Dividend Increase
-
Altria Recognized for Environmental Leadership
-
Altria Group (MO) Confirms FDA to Authorize Marketing of IQOS Tobacco Heating System as Modified Risk Tobacco Product
-
FDA Authorizes Marketing of the IQOS Tobacco Heating System as a Modified Risk Tobacco Product
-
Altria (MO) Said FDA to Begin Substantive Review of on! Nicotine Pouches
-
FDA to Begin Substantive Review of on!® Nicotine Pouches
-
Altria Announces Five Million Dollar Donation to Fight Racial Inequality
-
Altria Holds 2020 Annual Meeting of Shareholders; Declares Regular Quarterly Dividend of $0.84 Per Common Share
-
Altria Reports 2020 First-quarter Results; Core Tobacco Segments Deliver Strong OCI and Cash Flow; Withdraws Earnings Guidance Due to Uncertain COVID-19 Impacts on Diverse Business Model
-
Altria Group (MO) Chairman and CEO, Howard Willard, retires, Board elects Billy Gifford to serve as CEO
-
Altria Announces Leadership and Governance Changes
-
Altria to Defend FTC Action Against Minority Investment in JUUL
-
Altria Group (MO) Announces Temporary Suspension of Operations at the Richmond Manufacturing Center
-
Altria Announces Temporary Suspension of Operations at the Richmond Manufacturing Center
-
Altria Presents at the Consumer Analyst Group of New York Conference; Reaffirms Full-Year 2020 Earnings Guidance; Maintains 2020-2022 Adjusted Diluted EPS Growth Objective
-
Altria Reports 2019 Fourth-Quarter and Full-Year Results; Provides 2020 Full-Year Earnings Guidance; Revises 2020 - 2022 Adjusted Diluted EPS Growth Objective; Revises Terms of JUUL Transaction
-
Altria Group (MO) Lower as NY AG Sues JUUL Labs
-
Altria Reports 2019 Third-Quarter and Nine-Months Results; Announces New 2020 - 2022 Adjusted Diluted EPS Growth Objective to Advance Strategic Business Platform
-
Lexaria Bioscience Provides Update on R&D Program Progress under License Agreement with Altria
-
Altria Group (MO) confirms merger discussions with Philip Morris (PM) have ended, updates guidance
-
Altria and Philip Morris International End Merger Discussions; Altria Provides Statement on JUUL Leadership Change; Tightens 2019 Full-year Earnings Guidance
-
Altria Recommends Rejection of Amended Mini-Tender Offer by TRC
-
Altria Recommends Rejection of Mini-Tender Offer by TRC
-
Altria Group, Inc. Confirms Discussions With Philip Morris International, Inc. Regarding Potential All-Stock, Merger of Equals
-
Altria Reports 2019 Second-Quarter and First-Half Results; Reaffirms 2019 Full-Year Earnings Guidance and Announces New $1 Billion Share Repurchase Program
-
More than Half of U.S. Population Now Governed by State Laws Raising Minimum Age of Purchase for All Tobacco Products to 21
-
Altria Group (MO) Confirms Agreement to Buy 80% of Burger Group
-
Altria Enters Growing Oral Nicotine Products Category with on! Pouch Product
-
Altria Holds 2019 Annual Meeting of Shareholders
-
Altria Group (MO) Announces FDA Authorizes Sale of IQOS Tobacco Heating System in the U.S.
-
FDA Authorizes Sale of IQOS Tobacco Heating System in the U.S.
-
Altria Reports 2019 First-Quarter Results; Reaffirms 2019 Full-Year Earnings Guidance
-
Altria (MO) Says it Supports Federal Legislation to Raise Age of Purchase for All Tobacco Products to 21
-
Altria Supports Federal Legislation to Raise the Age of Purchase for All Tobacco Products to 21
-
Cronos Group (CRON) Closes C$2.4 Billion Strategic Growth Investment from Altria (MO)
-
Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc.
-
Altria Becomes Largest Shareholder in Cronos Group, a Leading Global Cannabinoid Company
-
Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc.
-
Cronos Group (CRON) Shareholders Approve C$2.4 Billion Strategic Investment from Altria Group (MO)
-
Cronos Group Inc. Shareholders Approve C$2.4 Billion Strategic Investment from Altria Group, Inc.
-
Cronos Group Inc. Shareholders Approve C$2.4 Billion Strategic Investment from Altria Group, Inc.
-
Altria Group (MO) Presents at CAGNY; Reaffirms Full-Year 2019 Earnings Guidance
-
Altria Presents at the Consumer Analyst Group of New York Conference; Reaffirms Full-Year 2019 Earnings Guidance
-
Altria Reports 2018 Fourth-Quarter and Full-Year Results; Provides 2019 Full-Year Earnings Guidance
-
Altria Group (MO) Reports Agreement for up to $12M Investment in Lexaria Bioscience Corp. (LXRP) DehydraTECH Technology
-
Altria Group Invests Up to $12M in Lexaria Bioscience’s DehydraTECH™ Technology
-
Altria Group Invests Up to $12M in Lexaria Bioscience’s DehydraTECH™ Technology

